Entries by will

Cellesce receives further funding to commercialise its Organoid Expansion technology

Cardiff-based life sciences company Cellesce is continuing to develop its organoid research thanks to a recent six-figure funding round led by Finance Wales. This injection of new capital will enable Cellesce to continue development of its organoid expansion technology and establish its growing team in the GE Innovation Village in Cardiff. Cellesce Founder and CTO, […]

,

Successful Completion of Organoid Technology project

Cellesce is pleased to announce that it has successfully completed its organoid technology development project. Funded by InnovateUK (the UK’s innovation agency) and NC3Rs (leading the discovery and application of new technologies and approaches to replace, reduce and refine the use of animals for scientific purposes), the project ran from September 2014 to February 2016. […]

Successful seed fundraising round and appointment of non-executive directors

Cellesce has successfully raised funds which will be used to complete the development of an innovative process for the expansion of organoids. Organoid models are a powerful new enabling technology in cancer drug discovery. Because organoids are closer to in vivo tissue structure than other available models, they give more accurate responses to drug candidates. […]

Cellesce and Cardiff University Collaborate on Organoid Project for Drug Screening

Cellesce is partnering with world-leading researchers at Cardiff University in an Innovate UK, the UK’s innovation agency and NC3Rs funded project to test the use of bioreactor and bioprocessing in the culture of organoids to enable market-wide drug screening. Cellesce, led by Dr Marianne Ellis, will be using its biochemical engineering expertise to develop a […]